Home › Leukemie › Alabama › Birmingham
Leukemie klinische studies in Birmingham, AL
10 studies voor Leukemie zoeken deelnemers op locaties in en rond Birmingham (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
RekruterenFase 3
- Quetzal Site 16, Birmingham
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
RekruterenFase 2
- University of Alabama - Birmingham, Birmingham
Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
RekruterenFase 2
- The University of Alabama at Birmingham, Birmingham
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
RekruterenFase 1/2
- Dren Investigational Site, Birmingham
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
RekruterenObservatieonderzoek
- Children's Hospital of Alabama, Birmingham
Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies
RekruterenFase 1
- University of Alabama at Birmingham, Birmingham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Birmingham
Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant
RekruterenFase 2
- University of Alabama at Birmingham, Birmingham
Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant
RekruterenFase 2
- University of Alabama at Birmingham, Birmingham
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
RekruterenFase 1
- University of Alabama at Birmingham, Birmingham
Leukemie studies in andere steden
- Houston, TX28 studies
- Boston, MA25 studies
- New York City, NY19 studies
- Los Angeles, CA16 studies
- Chicago, IL16 studies
- Durham, NC13 studies
- Baldwin Park, CA12 studies
- Columbus, OH12 studies
- Nashville, TN12 studies
- Philadelphia, PA12 studies
- Milwaukee, WI11 studies
- Atlanta, GA11 studies
Andere studies in Birmingham
- Kanker (alle vormen)30 studies
- Borstkanker24 studies
- Obesitas23 studies
- Eierstokkanker23 studies
- Niet-kleincellige longkanker22 studies
- Acute myeloïde leukemie21 studies
- Multipel myeloom18 studies
- COPD17 studies
- Cardiovasculaire ziekte17 studies
- Overgewicht16 studies
- Endometriumkanker16 studies
- Type 2-diabetes16 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.